Bannehr M, Lohr L, Gelep J, Haverkamp W, Schunck WH, Gollasch M, Wutzler A (2019)
Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts
Cardiovasc Toxicol 19: 365

Klocke J, Ulu A, Wu K, Rudolph B, Dragun D, Gollasch M, Schunck WH, Hammock BD, Riemekasten G, Enghard P (2019)
Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice
Sci Rep 9: 8993

Boldt C, Roeschel T, Himmerkus N, Plain A, Bleich M, Labes R, Blum M, Krause H, Magheli A, Giesecke T, Mutig K, Rothe M, Weldon SM, Dragun D, Schunck WH, Bachmann S, Paliege A (2016)
Vasopressin lowers renal epoxyeicosatrienoic acid levels by activating soluble epoxide hydrolase
American Journal of Physiology Renal Physiol

Wutzler A, Kestler C, Perrot A, Loehr L, Huemer M, Parwani AS, Attanasio P, Ozcelik C, Schunck WH, Gollasch M, Haverkamp W, Boldt LH (2013)
Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation
Int J Cardiol 168: 3647

Monti J, Fischer J, Paskas S, Heinig M, Schulz H, Gosele C, Heuser A, Fischer R, Schmidt C, Schirdewan A, Gross V, Hummel O, Maatz H, Patone G, Saar K, Vingron M, Weldon SM, Lindpaintner K, Hammock BD, Rohde K, Dietz R, Cook SA, Schunck WH, Luft FC, Hubner N (2008)
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease
Nat Genet 40: 529

Schwarz D, Kisselev P, Cascorbi I, Schunck WH, Roots I (2001)
Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants
Carcinogenesis 22: 453